Tadalafil 171596-29-5
- CasNo：171596-29-5
- Molecular Formula：C22H19N3O4
- Purity：
- Molecular Weight：
Product Details
|
171596-29-5 Name |
|
|
Name |
Tadalafil |
|
Synonym |
TADALAFIL;CIALIS;IC 351;(6R,12AR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido;GF 196960;ICOS 351;Tildenafil;UK 336017 |
|
171596-29-5 Chemical & Physical Properties |
|
|
Melting point |
298-300ºC |
|
Boiling point |
679.1±55.0 °C at 760 mmHg |
|
Density |
1.5±0.1 g/cm3 |
|
Molecular Formula |
C22H19N3O4 |
|
Molecular Weight |
389.404 |
|
Flash Point |
364.5±31.5 °C |
|
PSA |
74.87000 |
|
LogP |
1.43 |
|
Exact Mass |
389.137543 |
|
Vapour Pressure |
0.0±2.1 mmHg at 25°C |
|
Index of Refraction |
1.758 |
|
Storage condition |
Hygroscopic, -20?C Freezer, Under Inert Atmosphere |
|
171596-29-5 Description |
|
Tadalafil is a PDE5 inhibitor with an IC50 value of 1.8 nM.IC50 Value: 1.8±0.4nM [1]Target: PDE 5Tadalafil is marketed in pill form for treating erectile dysfunction(ED) under the name Cialis, and under the name Adcirca for the treatment of pulmonary arterial hypertension. Tadalafil can elevate the level of cGMP in the corpus cavernosum and effectively improve ED of various causes and degrees. |
|
171596-29-5 Uses |
|
